Find the Perfect Plan for Your Investment Journey
Last Price
52 Week Range
$0.42 - $0.95
Next Earnings Date
May 12 2025
Next Earnings Date
May 12 2025
Last Price
Market Cap | $48.84M |
EV | $50.20M |
Shares Outstanding | 100.09M |
Beta | 1.16 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | $2.92 |
P/E 2025E | - |
P/Revenue 2025E | 9.60x |
Revenue | 139.30% |
EPS | 15.30% |
Operating Cash Flow | -7.50% |
Free Cash Flow | -6.20% |
Revenue | 288.60% |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 85.70% |
Net Profit Margin 2025E | -267.70% |
ROE 2025E | - |
ROCE 2024 | - |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
VolitionRx Limited
VNRX
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Reynolds, Cameron
Employees
85
Website
www.volition.comIPO Date
2012-03-02
Headquarters
1489 West Warm Springs Road, Suite 110, Henderson, Nevada, 89014, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved